Hydrogen Gel Shows Promise for Treating Psoriasis in Mouse Study
Reshaping psoriasis topical therapy: Continuous hydrogenation orchestrates 'redox-metabolic homeostasis' for efficient remission and relapse intervention
Research hubs: Skin & Dermatology System
- Evidence type
- Animal study (mouse)
- Authors
- Lanmei Lin, Qingqing Guan, Zhiguang Ding, Jianxin Zou, Canbin Dong, Xinyi Zhu, Weijian Fan, Han Li, Jinhua Xu, Jinyun Tan, Wenjiang Ding, Jia Pei, Juan Du
- Journal
- Bioactive Materials
- Year
- 2026
- DOI
- 10.1016/j.bioactmat.2026.03.018
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Psoriasis
- Body System
- Integumentary
This research was done in animals. Results in animals often don't carry over to people.
TL;DR
A magnesium hydride microbubble hydrogel provided sustained topical hydrogen release and improved psoriasis-like skin pathology in preclinical models by reducing keratinocyte hyperproliferation, restoring redox balance, and modulating PKM2-linked energy metabolism.
Key Finding
A hydrogen-releasing hydrogel patch reduced psoriasis-like skin symptoms in mice more effectively than the standard drug Calcipotriol and an immune-stimulating comparison treatment.
Summary
Researchers developed a gel patch containing magnesium hydride nanoparticles that slowly releases hydrogen gas when applied to skin. In mouse studies of psoriasis (a chronic skin condition causing thick, inflamed patches), this hydrogen-releasing patch reduced skin thickening and inflammation better than two comparison treatments. The researchers found that hydrogen appears to work by slowing down the rapid multiplication of skin cells and reducing inflammatory signals in the body.
Practical Takeaway
This early-stage research in mice suggests hydrogen gas delivery to skin may help manage psoriasis by targeting the underlying metabolic and inflammatory processes. However, this is a mouse study only, and human trials would be needed before any conclusions about safety or effectiveness in people could be drawn. The work is still in the proof-of-concept phase and far from clinical application.
Abstract (excerpt)
Psoriasis represents a globally prevalent and chronic dermatological disorder, characterized by persistent hyperkeratosis, self-sustaining inflammatory cycles, and frequent relapse, posing substantial challenges for conventional therapies of compromised efficacy and biosafety. Here, we introduce…